Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 20, 2026 19:00 ET | Source: Essential Pharma

Essential Pharma 旗下公司 Renaissance Pharma Limited 用于治疗高危神经母细胞瘤的 Daretabart (hu1418K322A) 获得 FDA 快速通道认定，并通过 IND 审评

FDA 授予 Daretabart (hu1418K322A) 快速通道认定资格，以解决高危神经母细胞瘤领域存在的重大未满足医疗需求，允许该药物进入加速评审和滚动审评流程FDA 通过新药临床研究 (IND) 申请后，即可在高危神经母细胞瘤复发及难治性患者中启动 SHINE II/III 期临床试验Daretabart (hu1418K322A) 第一个商业化规模 GMP...
April 14, 2026 02:00 ET | Source: Essential Pharma

Renaissance Pharma Limited, an Essential Pharma company, secures FDA Fast Track Designation and IND clearance for Daretabart (hu1418K322A) in high-risk neuroblastoma

FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and enabling access to accelerated and rolling reviewFDA...
February 17, 2026 07:00 ET | Source: Essential Pharma

Essential Pharma strengthens rare disease portfolio with acquisition of Ventavis® (iloprost trometamol) for adult primary pulmonary hypertension

Ventavis® is an established inhaled prostacyclin analogue for the treatment of primary pulmonary hypertensionAcquisition reinforces Essential Pharma’s mission to serve the needs of rare disease...
July 03, 2025 03:00 ET | Source: Essential Pharma

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team

Essential Pharma appoints experienced pharmaceutical leaders Simon Ramsden and Rob Smith to leadership team Egham, UK – 03 July 2025 – Essential Pharma (“Essential” or “the Company”), a global...
June 25, 2025 03:00 ET | Source: Essential Pharma

Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director

Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director Egham, UK – 25 June 2025 – Essential Pharma (“Essential” or “the Company”), a global...
May 06, 2025 03:00 ET | Source: Essential Pharma

Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial

Egham, UK – 6th May 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients in niche populations, today announces the...
April 30, 2025 03:00 ET | Source: Essential Pharma

Essential Pharma strengthens Board with the appointment of Jonathan Arnold as Non-Executive Director

Essential Pharma strengthens Board with the appointment of Jonathan Arnold as Non-Executive DirectorEgham, UK – 30 April 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical...
February 06, 2025 03:00 ET | Source: Essential Pharma

Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC

Agreement drives continued patient access to four important therapies in Japan and Korea Strengthens Essential Pharma and Clinigen’s combined market presence in the JAPAC region Egham, UK – 6th...
December 12, 2024 02:00 ET | Source: Essential Pharma

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth Street Provides significant resources to...
October 16, 2024 02:00 ET | Source: Essential Pharma

Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer

Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer Newly established role at Essential Pharma further strengthens leadership team and supports global growth Dr Liz...